FTSV already proved that anti-CD47 was a viable anti-cancer approach and that is when I dramatically increased my shares of TRIL at prices from $0.45 through $2. The early TRIL data suggest TTI-621 and TTI-622 will be at least as good but likely superior. For me now I am deciding when to sell a bit to get back some if not all my investment so that I am playing with house money. I came close to doing that yesterday. Depending on how the stock goes as ASH draws closer, I may do it before ASH. I learned the hard way that it is better to make less than I could have than to lose more than I am comfortable with. Besides, if there is a nice run up, often there is a drop after as the old sell the news kicks in. That could provide a buying opportunity with the cash I accumulated by the pre-ASH selling.
You also have to consider that TRIL might issue another offering if the price rises again after ASH, say to generate another $100 million+. Can't have too much money on hand. We will see.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM